Sort by
Refine Your Search
-
than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoctoral researcher in building technology Profile The Structural Xploration Lab is seeking
-
to define user needs and translate them into technical solutions. Creating clear documentation to ensure easy maintenance and tool adoption by clients. Ensuring reliability of services with modern monitoring
-
the strategic plan for the launch of MCAS, intially focused on the EPFL Valais Wallis site, including its mission, governance structure, access model, service portfolio, and operating model. Design a financial
-
access to reliable, scalable, and innovative computing resources that enable world-class research. Main duties and responsibilities Service & Operations Run ICP as a responsive, service-driven platform
-
reshape the structure and function of the epigenome. Over the past years, we have shown that remodeling the chromatin 3D structure is a key driver of tumor development and progression and demonstrated how
-
fédérale de Lausanne (EPFL) is seeking a dynamic and reliable Administrative Assistant to support a professor and his laboratory. The candidate will ensure the smooth running of administrative processes and
-
: https://www.epfl.ch/labs/hobel/ For more information about Prof. Dusan Licina: https://people.epfl.ch/dusan.licina For more information about EPFL: https://www.epfl.ch/en/ For more information about Smart
-
the field of sustainable construction. The research integrates dynamic material value-chain analyses, ownership models, technical performance assessment, and design-for-disassembly strategies to support the
-
, networking, and GPU utilization. Help maintain reproducible training recipes, configuration files, launch scripts, and documentation. Work with researchers and CSCS engineers to improve the reliability and
-
protocols. In close collaboration with the lab of George Coukos (https://agora-cancer.ch/laboratory/coukos-lab/ ), we will derive protocols enabling rapid expansion of cancer-specific, autologous TILs